scispace - formally typeset
Search or ask a question

What is known about CDK-2 and viral infections? 


Best insight from top research papers

CDK-2, also known as cyclin-dependent kinase 2, plays a significant role in viral infections. It has been shown to interact with viral proteins and facilitate viral replication and synthesis of viral RNA . CDK-2 has been identified as a key host factor for the RNA-dependent RNA polymerase (RdRp) complex of SARS-CoV-2, the virus responsible for COVID-19. Inhibition of CDK-2 impairs viral RNA synthesis and SARS-CoV-2 infection, making it a potential target for the development of antiviral drugs . CDKs, including CDK-2, have also been found to have critical roles in various other viral infections, although the molecular processes underlying their functions are not fully understood . Furthermore, specific CDK inhibitors, which have been developed for cancer treatment, show potential for repurposing as antiviral drugs. These inhibitors could be effective in combating both old and emerging viruses, providing a novel therapeutic strategy .

Answers from top 5 papers

More filters
Papers (5)Insight
CDK-2 is not mentioned in the provided paper. The paper is about CDK8 and CDK19 inhibitors and their role in inhibiting HIV-1 reactivation and promoting provirus latency in T cells.
CDK-2 is a cyclin-dependent kinase that plays a role in viral infections as both DNA and RNA viruses modify CDK function to favor viral replication.
CDK-2 is not mentioned in the paper. The paper is about protein kinase CK2 and its role in controlling viral infection and the generation of cancer cells, specifically focusing on Epstein-Barr virus (EBV).
CDK2 has been shown to modulate replication of RNA viruses and is hijacked by SARS-CoV-2 to promote viral RNA replication. CDK inhibitors hold promise as pan-coronaviruses antivirals.
CDK-2's role in viral infections is not mentioned in the paper. The paper discusses the general functions of CDKs in viral infections but does not specifically mention CDK-2.

Related Questions

What is the role of cdk8?5 answersCDK8, a transcription-regulating kinase, plays diverse roles in different contexts. In colon cancer, CDK8 inhibition suppresses hepatic metastasis by downregulating TIMP3 and inducing MMPs via TGFβ/SMAD and Wnt/β-catenin pathways. In MYC-driven medulloblastoma, CDK8 is essential for sustaining MYC expression and ribosome biogenesis, with CDK8 inhibitors showing promise in reducing tumor growth. In Arabidopsis, CDK8 regulates lipid synthesis by modulating WRI1 expression through KIN10-mediated degradation. Moreover, in NK cells, CDK8 deletion enhances cytotoxicity and improves tumor surveillance, suggesting a suppressive effect of CDK8 on NK-cell activity. Additionally, a novel CDK8 inhibitor shows potent anti-AML activity by targeting CDK8 and phosphorylating STAT-1 and STAT-5, inhibiting AML cell proliferation.
What is meant by CDK?4 answersCDK stands for cyclin-dependent kinase. It is a protein family that plays a crucial role in regulating the progression of the cell cycle and is involved in various cellular processes. Cyclin-CDK complexes control the transitions between different phases of the cell cycle by executing signaling, transcriptional, and enzymatic events. These complexes are regulated through complex formation, phosphorylation, stability, subcellular localization, and association with CDK inhibitors. CDKs are important in the pathogenesis of cancer and developmental disorders due to their connection to cellular proliferation. Additionally, CDKs signal via hundreds of differentially encoded targets at precise times to provide a temporally ordered phosphorylation pattern required for cell division.
What is the relationship between CENPT and CDK1?5 answersCENPT interacts with CENP-E and this interaction is enhanced in mitotic lysates. CENP-E is a kinetochore protein involved in chromosome congression during mitosis. The phosphorylation of TRAMM, a protein that interacts with CENP-E, is regulated by CDK1. CDK1 is a master kinase for mitotic progression and is responsible for phosphorylating CENP-C, another essential kinetochore component. The phosphorylation of CENP-C by CDK1 promotes proper kinetochore assembly during mitosis. Therefore, the relationship between CENPT and CDK1 is that CDK1 phosphorylates TRAMM, which interacts with CENP-E, and also phosphorylates CENP-C, both of which are involved in kinetochore assembly during mitosis.
What is the role of CDK in pancreatic cancer?5 answersCDK5 plays a significant role in pancreatic cancer by promoting invasion, migration, and anchorage-independent growth in vitro, as well as orthotopic tumor formation and systemic metastases in vivo. CDK hyperactivation is linked to the dependency on mutant KRas in pancreatic cancer cells, and inhibiting CDK1, CDK2, CDK7, and CDK9 has similar effects as knocking out KRas. AT7519, a CDK1, 2, 7, and 9 inhibitor, has been identified as a potent inducer of apoptosis in mutant KRas-dependent pancreatic cancer cells and has shown efficacy in suppressing tumor growth in relevant models. These findings suggest that CDKs, particularly CDK5, are potential therapeutic targets for degrading Ras signaling and treating pancreatic cancer.
What make DENV-2 is more virulent?5 answersDENV-2 is more virulent due to its ability to evade the immune system and cause more severe disease. In a study conducted in Brazil, it was found that DENV-2 strains isolated during a severe epidemic in 2008 were genetically distinct from previous strains and correlated with increased disease severity. Another study in Central India revealed that DENV-2 had a higher potential for immune evasion and prolonged viremia compared to other serotypes, which may contribute to its increased virulence. Additionally, research on the interplay between the mosquito vector and DENV-2 showed that the virus collected in mosquito saliva induced more severe hemorrhage in mice and had altered growth characteristics compared to culture-derived DENV-2, suggesting that the mosquito vector may contribute to the increased virulence of DENV-2. Overall, these findings highlight various factors that contribute to the increased virulence of DENV-2.
What does the CDK4 protein do during infection?5 answersCDK4 is a protein involved in the cell cycle progression. During infection, CDK4 plays a role in the regulation of cyclin-dependent kinase activity. It assembles with D-type cyclins to form active protein kinases, which are important for cell cycle progression. In the context of H1N1 infection, quercetin, a natural compound, has been shown to inhibit the overexpression of CDK4 mRNA and protein caused by H1N1 infection. However, the specific role of CDK4 during infection is not explicitly mentioned in the abstracts provided.

See what other people are reading

What is the role of proteasome inhibitors in case of solid tumors?
4 answers
Proteasome inhibitors play a crucial role in the treatment of solid tumors by targeting the ubiquitin-proteasome system. While traditional covalent proteasome inhibitors like bortezomib and ixazomib have limited efficacy against solid tumors due to side effects and poor distribution, novel non-covalent proteasome inhibitors, such as the QL compounds, show promise in inhibiting tumor growth in solid cancers and multiple myeloma with improved pharmacokinetic properties. Additionally, strategies focusing on reducing the 26S/20S proteasome ratio by depleting specific subunits have shown effectiveness in killing aggressive cancer cells while sparing normal cells. Proteasome inhibitors impair the proteasome's function, which is vital for cancer cell survival, making them a potential therapeutic target for solid tumors like osteosarcoma. Combining proteasome inhibitors with other agents like obatoclax has shown synergistic growth inhibition and apoptosis induction in small cell lung cancer.
How have bacteriophages been discovered and studied as potential alternatives to antibiotics?
5 answers
Bacteriophages have been discovered and studied as potential alternatives to antibiotics due to the rise of antibiotic-resistant bacteria. Research has shown that phage therapy offers promising results in treating bacterial infections, especially those involving biofilms and multidrug-resistant strains. Studies have demonstrated that phages can be effective in combating infections caused by multidrug-resistant bacteria, including those posing risks to humans and animals. The synergy between phages and antibiotics has been observed, with combined treatments showing increased efficacy in eliminating biofilms and combating severe bacterial infections. Furthermore, the use of phage cocktails targeting different cell surface receptors has been found to enhance the suppression of antibiotic-resistant bacteria, highlighting the potential of phage therapy as a valuable alternative to traditional antibiotics.
Does manganese concentration increases during phage infection?
5 answers
Yes, manganese concentration can increase during phage infection. Research has shown that exposure to manganese can accelerate the lytic effect of phage on susceptible bacteria, leading to an increase in extracellular phage concentration by up to four times compared to controls. Additionally, during infection, hosts impose manganese limitation on pathogens as a defense mechanism, which pathogens counter through adaptations like high-affinity manganese transporters. Furthermore, a study involving a phage-Chlorin e6-manganese dioxide nanocomposite demonstrated efficient delivery of manganese within biofilms, triggering robust reactive oxygen species production and releasing Mn2+ during infection. These findings collectively suggest that manganese concentration can indeed increase during phage infection, impacting bacterial susceptibility and host-pathogen interactions.
What is the Nanoparticle-based delivery systems in HCC?
4 answers
Nanoparticle-based delivery systems play a crucial role in targeted therapy for Hepatocellular Carcinoma (HCC). Various nanocarriers have been developed to enhance the efficacy of anticancer drugs while minimizing side effects. These nanocarriers can be functionalized with ligands like transferrin, folic acid, polypeptides, and hyaluronic acid to specifically target cancer cells. Nanotechnology has enabled the development of arsenic trioxide (ATO)-loaded nanocarriers, addressing challenges like optimal concentration and bioavailability of ATO for effective HCC treatment. Additionally, controlled-release biodegradable hydrogels have been explored as effective drug delivery systems for HCC, offering localized chemotherapy to reduce side effects and improve treatment outcomes. Novel dual-targeting nanocarrier systems, such as AR-NADR, have been designed to combat drug resistance in HCC by delivering cisplatin and NOR1 shRNA effectively. Gold-capped mesoporous silica nanoparticles have been utilized for liver-targeted delivery of cytotoxic molecules, showcasing promising anti-cancer activity against HCC cells.
Isolation of streptomyces in Egypt
5 answers
Streptomyces isolation in Egypt has been extensively studied in various extreme environments. Actinobacteria, including Streptomyces, have been isolated from locations like Wadi Al-Natrun, the Red Sea, the Mediterranean Sea, and the Sinai desert, showcasing their bioactive potential. These isolates have demonstrated antimicrobial activities against a range of pathogens, including multidrug-resistant strains like MRSA. Streptomyces sp. MMM2 and Streptomyces sp. DH7 are examples of potent isolates producing bioactive compounds with antimicrobial properties. Additionally, a novel bacteriophage, SscP1EGY, has been identified in Egypt for controlling Streptomyces scabies, a pathogen causing potato common scab, highlighting the diverse strategies for combating microbial infections in the region.
What are the primary metabolic pathways involved in the degradation of polyethylene (PET)?
4 answers
The degradation of polyethylene terephthalate (PET) involves several key metabolic pathways. Enzymatic breakdown plays a crucial role, with endo-lytic activity being a significant parameter for enzyme performance. Ionic liquids (ILs) have shown high catalytic activity in PET degradation, with cations attacking the carbonyl oxygen and anions forming strong H-bonds with PET and ethylene glycol, facilitating the cleavage of the C-O ester bond. DFT studies have revealed that enzymes like neprilysin and cutinase-like enzyme utilize mechanisms such as metal-bound hydroxide attack and general acid/base mechanisms for PET hydrolysis, with the former being energetically more favorable. Mechanoenzymatic reactions, particularly utilizing ball milling cycles, have shown increased PET degradation yields and reduced solvent requirements, offering a scalable and efficient method for PET breakdown.
What is the amidase protein found in Listeria Monocytogenes?
5 answers
The amidase proteins found in Listeria monocytogenes play crucial roles in cell wall hydrolysis and biofilm inhibition. Various studies have identified different amidase proteins in L. monocytogenes, such as the 293-amidase, Ami, and PlyLM. These amidases exhibit lytic activity against L. monocytogenes strains, including serotypes 4b and 1/2b-3b-7, aiding in cell lysis and biofilm disruption. The recombinant 293-amidase has shown broad specificity and inhibitory effects on biofilm formation at different temperatures. Additionally, the Ami protein, with its C-terminal cell wall anchoring domain, is involved in bacterial adhesion to mammalian cells. Understanding the properties and functions of these amidase proteins is essential for developing antimicrobial strategies against L. monocytogenes in food production environments.
How can antibacterial peptides be administered to treat pneumonia caused by A. baumannii?
5 answers
Antibacterial peptides can be administered to treat pneumonia caused by A. baumannii through various methods. Studies have shown that peptides like LyeTx I mnΔK, derived from spider venom, exhibit significant antibacterial activity against carbapenem-resistant A. baumannii (CRAB). Additionally, AMP derivatives like dN4 and dC4 have been identified as potential treatments for A. baumannii-induced pneumonia, showing prophylactic effects in mouse models and inhibiting biofilms. Furthermore, peptide analogues based on the eosinophil cationic protein have demonstrated efficacy in treating A. baumannii infections, with high survival rates and reduced tissue infection in murine models. These findings suggest that antibacterial peptides can be administered intravenously or through inhalation to effectively combat A. baumannii-induced pneumonia, offering promising alternatives to traditional antibiotics.
OMVs from A. baumannii may be utilized as novel therapeutic and prophylactic strategies?
5 answers
OMVs (outer membrane vesicles) from Acinetobacter baumannii show promise as novel therapeutic and prophylactic strategies. Research highlights the potential of OMVs in generating antibodies against A. baumannii cell surface targets, such as the CsuA/B protein subunit, with high specificity and affinity. Additionally, OMVs released by A. baumannii act as decoys against polymyxin B (PMB), protecting susceptible bacteria and even human gut microbiomes from PMB treatment. These findings suggest that OMVs could be utilized for developing targeted therapies and vaccines against A. baumannii infections, offering a new approach to combat multidrug-resistant strains of this pathogen. The use of OMVs as therapeutic agents presents a promising avenue for addressing the challenges posed by A. baumannii infections.
What is the mechanism of action of pyridopyrimidines?
5 answers
Pyridopyrimidines exhibit diverse mechanisms of action in cancer treatment. They act as growth inhibitors by inducing cell cycle arrest, apoptosis, inhibiting angiogenesis, disrupting cell migration, and targeting specific receptors and enzymes like dihydrofolate reductase, tyrosine kinase, cyclin-dependent kinase-4 and 6, and fibroblast growth factor receptor. Additionally, pyridopyrimidines can affect intracellular cyclic nucleotide accumulation, leading to the inhibition of secretory diarrhea. In the context of oncology, pyridopyrimidines based on compound 1 have shown promising antiproliferative activity by suppressing cell migration, inducing apoptosis, reducing phosphorylated ERK and MEK levels, and increasing ROS production. These compounds target various pathways crucial for cancer cell survival and proliferation, making them potential candidates for cancer therapy.
What is the role of pyridopyrimidines in the treatment of cancer?
4 answers
Pyridopyrimidines play a crucial role in cancer treatment due to their development as effective anticancer agents. These compounds are synthesized through various multi-component reactions, such as Tandemaza-witting reaction and Biginelli type reactions, leading to the creation of molecules with anticancer properties. Pyridopyrimidines have shown potential in inhibiting key receptors and enzymes responsible for cancer progression, including tyrosine kinase, cyclin-dependent kinase, and fibroblast growth factor receptor. Furthermore, pyridine-based compounds, which are prevalent in chemotherapeutic agents, exhibit diverse mechanisms of action against tumor cells, such as inhibiting antiapoptotic proteins, stimulating apoptotic pathways, and causing cell cycle arrest or DNA damage. In silico studies have also identified specific pyridopyrimidine derivatives with promising cytotoxic effects, indicating their potential for further exploration in cancer therapy.